Dr. Nadir Ali is an interventional cardiologist with over 25 years of experience. He is also the chairman of the Department of Cardiology at Clear Lake Regional Medical Center. Before working as a cardiologist, he served as an assistant professor of medicine for eight years at Baylor College of Medicine in Houston, where he also received his medical training.

Dr. Ali has championed many aspects of the science and practice of a low-carb lifestyle in the local Clear Lake area since 2013. He organises a monthly nutritional seminar in the Searcy Auditorium of the Clear Lake Hospital that receives more than 100 visitors every month from the local community. Dr Ali’s focus is on managing heart disease, obesity, metabolic syndrome and diabetes.

David. M. Diamond received his Ph.D. in Biology in 1985, with a specialization in Behavioral Neuroscience, from the Center for the Neurobiology of Learning and Memory at the University of California, Irvine. He is a professor in the Departments of Psychology and Molecular Pharmacology and Physiology at the University of South Florida, where he has directed his research program on post-traumatic stress disorder (PTSD).

Dr. Diamond has served on federal government study sections and committees evaluating research on the neurobiology of stress and memory, and has over 100 publications, reviews and book chapters on the brain and memory. He has served on the editorial boards of numerous medical journals and has received 30 years of federally funded support for his research.

In the past decade, Dr. Diamond has expanded his research program to include cardiovascular disease and nutrition. His controversial research is an extension of an advanced seminar he directs at the University of South Florida entitled “Myths and Deception in Medical Research”, which emphasizes the critical evaluation of methods and conflicts of interest in health-related research.

In recent years he added to his list of publications controversial papers on diet, cholesterol and statins, including one paper published in the peer- reviewed medical journal “Expert Review of Clinical Pharmacology”, which described the deceptive practices employed by researchers promoting statins for the treatment of cardiovascular disease. Dr. Diamond has been invited to present his myth-busting views on nutrition and cholesterol to lay people and physicians at nutrition, cardiology, obesity and diabetes conferences all over the world.

Professor David Diamond says you have been misled and deceived when it comes to LDL cholesterol and statins. But he isn't just going to tell you his opinion. He wants to show you the science. In his quest to set the record straight, he has been compared to "anti vaxers" and been called "dangerous." But the fascinating thing is that he is pointing out data that is in published, respected, peer-reviewed journals and showing a vastly different perspective than what we "know" about cholesterol and statins. 

In a world of pharma industry influence and a medical culture that isn't good at reevaluating its beliefs, it's important to have voices like Dr. Diamond's to help us realize the science is far from settled. Please remember, this is meant for educational purposes only and in no way constitutes medical advice. Please contact your physician before making any changes or medical decisions.

Low Carb Houston 2019 was held in Clear Lake at the University of Houston Clear Lake in October.

David M. Diamond received his Ph.D. in Biology in 1985, with a specialization in Behavioral Neuroscience, from the Center for the Neurobiology of Learning and Memory at the University of California, Irvine. He is a professor in the Departments of Psychology and Molecular Pharmacology and Physiology at the University of South Florida, where he has directed his research program on post-traumatic stress disorder (PTSD).

Dr. Diamond has served on federal government study sections and committees evaluating research on the neurobiology of stress and memory, and has over 100 publications, reviews and book chapters on the brain and memory. He has served on the editorial boards of numerous medical journals and has received 30 years of federally funded support for his research.

In the past decade, Dr. Diamond has expanded his research program to include cardiovascular disease and nutrition. His controversial research is an extension of an advanced seminar he directs at the University of South Florida entitled “Myths and Deception in Medical Research”, which emphasizes the critical evaluation of methods and conflicts of interest in health-related research.

In recent years he added to his list of publications controversial papers on diet, cholesterol and statins, including one paper published in the peer- reviewed medical journal “Expert Review of Clinical Pharmacology”, which described the deceptive practices employed by researchers promoting statins for the treatment of cardiovascular disease. Dr. Diamond has been invited to present his myth-busting views on nutrition and cholesterol to lay people and physicians at nutrition, cardiology, obesity and diabetes conferences all over the world. 

Dave Feldman is a senior software engineer, business developer and entrepreneur. He began a Low Carb, High Fat diet in April 2015 and after experiencing a significant rise in his total cholesterol he committed himself to learning everything he could about cholesterol and the lipid system.

As an engineer, Dave spotted a pattern in the lipid system that’s very similar to distributed objects in networks. Through research and N=1 experimentation he has revealed some very powerful data which he continues to share in this presentation and in further detail on his website www.CholesterolCode.com.

Dave Feldman has done more to call into question the lipid hypothesis of heart disease than practically anyone over the past few decades. His self experimentation and his theories on an energy model for lipids question the foundation of the theory that LDL is "bad" and we should all strive for a low level. He recently had his model "stress tested" on the Peter Attia podcast which for some created more questions than answers. 

In this episode, we review his energy model and inversion pattern, and we explore what this means for low carb individuals with elevated LDL levels. Since there are no clear answers, it helps to explore the possibilities so that we can try to make sense of this unique and unstudied area of lipidology.

A new study scientifically defines the group of people whose LDL cholesterol rises dramatically after starting a low-carb diet — so-called lean mass hyper-responders. But what does this mean if you are in this group, and what does it mean for the broader topic of cholesterol?

Does an elevated LDL cholesterol on a low-carb diet confer the same risk as an elevated LDL on a standard American diet? We don’t know the answer for certain. But thanks to Dave Feldman and his colleagues, we may learn the answer sooner rather than later.

Dave Feldman released preliminary data from a lean mass hyper-responder study that investigates elevated LDL while on a keto diet. He presented the baseline data at the Symposium for Metabolic Health in San Diego, and the reaction was notable — both supportive and critical.

The results of the study have the potential to change how we view elevated LDL cholesterol. But for now, we have to be patient for the end results and cautiously take away the lessons we can from the preliminary data.

This lecture is part 1 of 4 delivered by Dr Paul Mason at the Low Carb Down Under Gold Coast conference in October 2022. Dr Mason demolishes the weak science that LDL cholesterol is inherently harmful, and brings nuance to the conversation in a way that can be easily understood.

This lecture is part 2 of 3 delivered by Dr Mason at the Low Carb Down Under Gold Coast conference in October 2022. Dr Mason exposes the catastrophic harms caused by the first cholesterol lowering drug, Triparanol, and the guilty verdict that followed. 

This is followed by a brief history of statins, including the high rates of cancer in test animals seen with the first statin to come to market, and the massive (+$1,000,000,000) legal payouts made to settle lawsuits from statin side effects.

Specific statin side effects, including dementia are covered, followed by a close analysis of the measurable benefits that may be attributed to statins. This includes a review of a recent paper co-authored by David Diamond, Ben Bikman and Paul Mason that discusses how to identify who is likely and not likely to benefit from statin therapy using triglyceride and LDL levels.